Health TidingsCoya Therapeutics Secures FDA Fast Track Tag for COYA 302 in ALS Coya Therapeutics Secures FDA Fast Track Tag for COYA 302 in ALS Read Post »
Health TidingsGyre Gains NMPA NDA Acceptance for F351 Liver Fibrosis Therapy Gyre Gains NMPA NDA Acceptance for F351 Liver Fibrosis Therapy Read Post »
Clinical TrialsEncoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Encoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Read Post »
Clinical TrialsKura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Kura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Read Post »
Clinical TrialsNovo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Novo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Read Post »
Regulatory & Health PolicyFDA Seeks Public Input on Drug Repurposing Opportunities FDA Seeks Public Input on Drug Repurposing Opportunities Read Post »
Clinical TrialsAstellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Astellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Read Post »
Clinical TrialsLilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Lilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Read Post »
Health TidingsAgios Targets Accelerated Approval for Mitapivat in Sickle Cell Disease Agios Targets Accelerated Approval for Mitapivat in Sickle Cell Disease Read Post »
Mergers & AcquisitionsBoehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Boehringer Ingelheim Licenses Preclinical Antibody from Immunitas for Infla... Read Post »
Clinical TrialsAlnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Alnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Read Post »
Health TidingsServier’s Emi-Le Receives FDA Breakthrough Therapy Designation for Adenoi... Servier’s Emi-Le Receives FDA Breakthrough Therapy Designation for Adenoi... Read Post »
Clinical TrialsNovo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Novo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Read Post »
Mergers & AcquisitionsRigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Rigel Acquires Global Rights to Arvinas and Pfizer’s VEPPANU Read Post »
Clinical TrialsBridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder BridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder Read Post »
Clinical TrialsAstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... AstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... Read Post »
Clinical TrialsNovo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Novo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Read Post »
ManufacturingMacroGenics Hands Bora the Keys to Its Maryland Manufacturing Engine MacroGenics Hands Bora the Keys to Its Maryland Manufacturing Engine Read Post »
Health Tidings Mergers & AcquisitionsBMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance BMS and Hengrui Forge a $15.2 Billion Drug Discovery Alliance Read Post »
Clinical TrialsCytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Cytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Read Post »
GenericsTranspire Stakes Its Claim in the Generic Trelegy Ellipta Race Transpire Stakes Its Claim in the Generic Trelegy Ellipta Race Read Post »
Drugs Safety AlertMHRA Reinforces Safety Advice for Men Taking Finasteride and Dutasteride MHRA Reinforces Safety Advice for Men Taking Finasteride and Dutasteride Read Post »
ResearchFibroBiologics Advancing Development of a Fibroblast Treatment for Hantavir... FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavir... Read Post »
Clinical TrialsBridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... BridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... Read Post »
Clinical TrialsViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA ViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA Read Post »
Health Tidings Mergers & AcquisitionsGSK Aligns With CTTQ to Expand Access to Bepirovirsen in China GSK Aligns With CTTQ to Expand Access to Bepirovirsen in China Read Post »
Health Tidings Mergers & AcquisitionsOncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Oncotelic-Lunai N2B Deal Gains Momentum Amid Rising Focus on CNS Drug Deliv... Read Post »
Health TidingsZai Lab Puts Zoci on the Fast Track in the Race Against epNEC Zai Lab Puts Zoci on the Fast Track in the Race Against epNEC Read Post »
New Drug ApprovalHenlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Henlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Read Post »
Health TidingsInnovent Biologics Moves IBI363 Into Phase III After China Breakthrough Nod Innovent Biologics Moves IBI363 Into Phase III After China Breakthrough Nod Read Post »
Health TidingsMoonLake Aligns with FDA on BLA Strategy for SLK in Hidradenitis Suppurativ... MoonLake Aligns with FDA on BLA Strategy for SLK in Hidradenitis Suppurativ... Read Post »
Regulatory & Health PolicyFDA Lays the Groundwork for Better Pregnancy Drug Safety Evidence FDA Lays the Groundwork for Better Pregnancy Drug Safety Evidence Read Post »
New Drug ApprovalFDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma FDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma Read Post »
New Drug ApprovalFDA Approves VYVGART for All Adult gMG Antibody Subtypes FDA Approves VYVGART for All Adult gMG Antibody Subtypes Read Post »
New Drug ApprovalGenentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Genentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Read Post »
Health TidingsServier and Day One Complete Enrollment in Phase 3 OJEMDA Glioma Trial Servier and Day One Complete Enrollment in Phase 3 OJEMDA Glioma Trial Read Post »
Health TidingsCapricor Files Lawsuit Against NS Pharma Over Deramiocel Access Capricor Files Lawsuit Against NS Pharma Over Deramiocel Access Read Post »
Clinical TrialsAtsena Presents Encouraging Long-Term Data in XLRS and LCA1 Atsena Presents Encouraging Long-Term Data in XLRS and LCA1 Read Post »
New Drug ApprovalEU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis EU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis Read Post »
New Drug ApprovalInnovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Innovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Read Post »
New Drug ApprovalNICE Recommends Givinostat for Ambulant DMD Patients Aged 6+ via NHS Innova... NICE Recommends Givinostat for Ambulant DMD Patients Aged 6+ via NHS Innova... Read Post »
Health TidingsEisai and Biogen Face Three-Month FDA Delay for LEQEMBI sBLA Eisai and Biogen Face Three-Month FDA Delay for LEQEMBI sBLA Read Post »
New Drug ApprovalMHRA Authorizes Dawnzera for Patients With Hereditary Angioedema MHRA Authorizes Dawnzera for Patients With Hereditary Angioedema Read Post »
Mergers & AcquisitionsRoche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Roche to Acquire PathAI in Up to $1.05 Billion Digital Pathology Deal Read Post »
Health TidingsAtara and Pierre Fabre Aligns with FDA on Tab-cel BLA Resubmission Path Atara and Pierre Fabre Aligns with FDA on Tab-cel BLA Resubmission Path Read Post »
Health TidingsBayer Wins China Priority Review for Asundexian in Stroke Prevention Bayer Wins China Priority Review for Asundexian in Stroke Prevention Read Post »
ResearchJohnson & Johnson Pushes for Full Depression Recovery Through Generatio... Johnson & Johnson Pushes for Full Depression Recovery Through Generatio... Read Post »
Clinical TrialsFDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality FDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality Read Post »
Health TidingsAvalo Reports Positive Phase 2 Results for Abdakibart in HS Avalo Reports Positive Phase 2 Results for Abdakibart in HS Read Post »
Health TidingsBIZENGRI Receives FDA Priority Voucher in NRG1+ Cholangiocarcinoma BIZENGRI Receives FDA Priority Voucher in NRG1+ Cholangiocarcinoma Read Post »
